Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

Delayed Data
As of 3:50pm ET
 -0.04 / -0.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 13.74, with a high estimate of 18.84 and a low estimate of 11.71. The median estimate represents a -4.90% decrease from the last price of 14.45.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in Astellas Pharma Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -45.98%
Growthannually -11.48%


Growthquarterly -14.70%
Growthannually 2.52%
Key to the earnings and sales forecast charts.